Mia D. Sorensen - Publications

Paired Liver Biopsies vs Noninvasive Tests as Surrogate Endpoints for Clinical Trials in Metabolic and Alcohol-Related Liver Disease and Alcohol-Related Liver Disease.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: September 26, 2025

A Novel Case of Indolent T-Lymphoblastic Proliferation in Metastatic High-Grade Serous Adenocarcinoma.

Journal: International journal of laboratory hematology

Published: April 25, 2025

Reduced CD20 expression yields inferior survival in patients with B-cell lymphoma treated with CD20×CD3 antibodies.

Journal: Blood neoplasia

Published: December 02, 2024

Risk and prognosis of posttransplant lymphoproliferative disease in Epstein-Barr virus-seronegative kidney transplant recipients - an observational cohort study from Norway and western Denmark.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: August 24, 2024

Microglia induce an interferon-stimulated gene expression profile in glioblastoma and increase glioblastoma resistance to temozolomide.

Journal: Neuropathology and applied neurobiology

Published: November 27, 2023

D-2-hydroxyglutarate regulates human brain vascular endothelial cell proliferation and barrier function.

Journal: Journal of neuropathology and experimental neurology

Published: September 23, 2023

Alcohol use and hepatocellular carcinoma risk in patients with alcohol-related cirrhosis.

Journal: Scandinavian journal of gastroenterology

Published: June 08, 2023

Investigating hypozincemia and validity of plasma zinc measurements in infected patients.

Journal: Scandinavian journal of clinical and laboratory investigation

Published: September 05, 2022

Albumin-corrected Zn and available free Zn-binding capacity as indicators of Zn status - potential for clinical implementation.

Journal: Scandinavian journal of clinical and laboratory investigation

Published: June 27, 2022

The Epigenetic Regulator Jumonji Domain-Containing Protein 6 (JMJD6) Is Highly Expressed but Not Prognostic in IDH-Wildtype Glioblastoma Patients.

Journal: Journal of neuropathology and experimental neurology

Published: December 07, 2021

Stage-dependent expression of fibrogenic markers in alcohol-related liver disease.

Journal: Pathology, research and practice

Published: August 28, 2021

Expression and Prognostic Value of the Immune Checkpoints Galectin-9 and PD-L1 in Glioblastomas.

Journal: Journal of neuropathology and experimental neurology

Published: May 15, 2021